On December 2, 2025, ProPhase Labs, Inc. completed a reverse stock split, converting every ten shares into one share to boost the stock price for compliance with NASDAQ listing rules, resulting in approximately 5,768,951 shares outstanding. This decision was approved by shareholders on November 30, 2025, during a Special Meeting.